Sumitomo Dainippon Pharma (Japan)
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Sumitomo Dainippon Pharma (Japan), Japan, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
45%
Total
Publications
1.7K
Total Open
Publications
770
Total
Citations
47K
Open Access
Percentage
45%
Total
Publications
1.7K
Total Open
Publications
770
Total
Citations
47K
Breakdown
Publisher Open
23%
Both
17%
Other Platform Open
5%
Closed
55%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 25%
174
Hybrid 24%
164
No Guarantees 51%
351
Other Platform Open
Domain 85%
314
Institution 16%
58
Public 10%
38
Preprint 7%
26
Other Internet 6%
22
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 314 |
Europe PMC | Domain | 159 |
Semantic Scholar | Public | 34 |
DOI | Other Internet | 18 |
Kyoto University - Kyoto University Research Information Repository | Institution | 15 |
Research Square | Preprint | 13 |
bioRxiv | Preprint | 10 |
Hokkaido University - Hokkaido University Collection of Scholarly and Academic Papers | Institution | 9 |
Figshare | Public | 8 |
University College London - UCL Discovery | Institution | 6 |